HOME
PRODUCTS
TRIAGE SYSTEM
CARDIAC PANEL
BNP TEST
Heart Failure
BNP Defined
Economics & Diagnosis
Algorithms
Product Info
Beckman Coulter® Immunoassay Systems
Publications / Abstracts
BNP Slide Set
Case Studies
ED Patient 1
ED Patient 2
Outpatient A
Outpatient B
Outpatient C
Ordering Info
Request Info
Customer Service
FAQs
Resources
PROFILER SHORTNESS OF BREATH PANEL
D-DIMER TEST
TOX DRUG SCREEN
DRUGS OF ABUSE PANEL
C. difficile PANEL
PARASITE PANEL
REIMBURSEMENT
Biosite Inc.

Heart Failure and Health Economics

Heart failure is a frequent reason for hospitalization in the elderly. In 2002, 979,000 hospital discharges were attributed to heart failure. From 1999-2002, deaths from heart failure increased 35 percent, outpacing the overall U.S. death rate of 7.7 percent.1

The American Heart Association estimates that direct medical costs for heart failure will amount to $25.3 billion in 2005, including $14.7 billion for hospitalization alone.1 Indirect costs for lost productivity and death associated with the disease are estimated to be nearly $2 billion.2

Heart Failure: A Challenging Diagnosis

  • Clinical assessment is subjective.
  • Early stages are asymptomatic and undetectable.3
  • Late stages present nonspecific signs and symptoms.
  • Heart failure is a difficult diagnosis and up to one-half of diagnoses made in primary healthcare may be incorrect.4,5
  • The use of BNP may reduce both the time to hospital discharge and the cost of treatment.6

References